Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study
Evaluation of real-world implementation of HER2 testing showed that uptake was high (>90%) and trastuzumab treatment was targeted to patients with positive HER2 status.
Timing of Follow-up After Abnormal Screening and Diagnostic Mammograms
Woman-level characteristics such as breast symptoms at mammography are associated with earlier follow-up within an integrated health system with an active breast health plan.
2 Clarke Drive Cranbury, NJ 08512